Graduate
Jeff Packman has been appointed chief development officer at Clementia Pharmaceuticals, a biotechnology company headquartered in Montreal. He is responsible for implementing the company’s global regulatory strategy, clinical operations, and manufacturing activities. Previously, he was chief development officer at Apofore Corp., which focuses on diabetes therapeutics.